Review3 Biotech2025
Emerging trends of biomedical nanotechnology in nutrition, health monitoring and disease diagnosis.
Review in 3 Biotech, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The transdisciplinary nature of nanotechnology has facilitated its application across various fields, especially in biological sciences. The primary aim of this review is to consolidate the many facets of nanomedicine, theranostics, and nanotechnology in food preservation into a unified framework and to underscore established research methodologies in the medical domain. Nanoparticles serve a crucial function in improving the bioavailability of orally delivered bioactive substances. This review demonstrated that nanoparticles can enhance the bioavailability of micronutrients, such as vitamin B12, vitamin A, folic acid, and iron. New advances in nanotechnology have made big differences in finding pathogens and killing them specifically, helping people to get better health through medication delivery and imaging, improving food packaging better so it lasts longer, and making foods healthier overall. Nanotechnology currently enhances the safety of delivering highly hazardous medicines through the use of nanozymes that exhibit antioxidant and antibacterial characteristics. Moreover, wearable devices can identify significant alterations in vital signs, medical problems, and infections occurring within the body. We anticipate that these technologies will provide physicians with enhanced direct access to crucial information about the causes of changes in vital signs or diseases, as they are directly connected to the source of the problem. This review paper thoroughly examines the latest developments in nanomaterials and nanozymes as antimicrobial agents in food science and nutrition, wound healing, illness diagnostics, imaging, and potential future uses. The paper presents a concise and structured report on nanotechnology, which will be beneficial to researchers and scientists for future research opportunities.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.